Targeting PP2A-dependent autophagy enhances sensitivity to ruxolitinib in JAK2V617F myeloproliferative neoplasms.
Courdy C, Platteeuw L, Ducau C, De Araujo I, Boet E, Sahal A, Saland E, Edmond V, Tavitian S, Bertoli S, Cougoul P, Granat F, Poillet L, Marty C, Plo I, Sarry JE, Manenti S, Mansat-De Mas V, Joffre C.
Courdy C, et al. Among authors: edmond v.
Blood Cancer J. 2023 Jul 10;13(1):106. doi: 10.1038/s41408-023-00875-x.
Blood Cancer J. 2023.
PMID: 37423955
Free PMC article.